4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001209191-23-031880
Options or other derivatives
- Director acquired 13,043,478 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2023-05-22 | Grant or award · Prelude Non-Voting Common Stock | +121,178 | $5.75 | $696,774 | 630,658 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-22 | Grant or award · Prelude Non-Voting Common Stock | +1,327,044 | $5.75 | $7,630,503 | 6,539,415 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-22 | Grant or award · Warrants to purchase Common Stock | +970,220 | $5.75 | $5,578,668 | 970,220 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-22 | Grant or award · Warrants to purchase Common Stock | +10,625,036 | $5.75 | $61,092,894 | 10,625,036 | I |
Loading xslF345X04/doc4.xml…